triazine derivatives (Monash University/MMV/Griffith Univ/Univ of Melbourne)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nametriazine derivatives (Monash University/MMV/Griffith Univ/Univ of Melbourne)
Drug Alias Nameantimalarial bis-triazines (Monash University/MMV/Griffith Univ/Univ of Melbourne)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMonash University
China Registration ClassN/A

Develop Information

Active CompaniesGriffith UniversityMonash UniversityUniversity Of Melbourne +[4] 
Inactive CompaniesN/A
Active IndicationsMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A